or Try an Advanced Search...

    Technical Analysis for BIAF - bioAffinity Technologies, Inc.

    Grade Last Price % Change Price Change
    D 2.26 -7.76% -0.19
    BIAF closed down 7.76 percent on Friday, May 17, 2024, on 70 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Flat Up
    Historical BIAF trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Crossed Above 20 DMA Bullish -7.76%
    Crossed Above 50 DMA Bullish -7.76%
    Expansion Pivot Buy Setup Bullish Swing Setup -7.76%
    Pocket Pivot Bullish Swing Setup -7.76%
    Wide Range Bar Range Expansion -7.76%
    Wide Bands Range Expansion -7.76%
    Older End-of-Day Signals for BIAF ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR 1 day ago
    Down 10% 1 day ago
    20 DMA Support 1 day ago
    50 DMA Support 1 day ago
    Fell Below 50 DMA 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BIAF Chart by TradingView
    Basic chart:

    Profile

    bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Cancer Life Sciences Biology Diagnostic Tests Lung Cancer Molecular Diagnostics Cancer Therapeutics

    Is BIAF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 bioAffinity Technologies GAAP EPS of -$0.21, revenue of $2.4M
    May 15 bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
    Apr 24 bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
    Apr 9 bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
    Apr 4 bioAffinity Technologies files to sell 1.63M shares for holders
    Apr 1 bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 8 Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
    Mar 8 bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
    Mar 6 WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
    Mar 6 BioAffinity Technologies to raise $2.5M from stock offering and private placement
    See more BIAF news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.62
    52 Week Low 0.9548
    Average Volume 189,585
    200-Day Moving Average 1.73
    50-Day Moving Average 2.27
    20-Day Moving Average 2.26
    10-Day Moving Average 2.06
    Average True Range 0.27
    RSI (14) 50.74
    ADX 20.65
    +DI 28.04
    -DI 16.03
    Chandelier Exit (Long, 3 ATRs) 2.36
    Chandelier Exit (Short, 3 ATRs) 2.60
    Upper Bollinger Bands 2.82
    Lower Bollinger Band 1.70
    Percent B (%b) 0.5
    BandWidth 49.81
    MACD Line -0.07
    MACD Signal Line -0.07
    MACD Histogram -0.0029
    Fundamentals Value
    Market Cap 21.48 Million
    Num Shares 9.5 Million
    EPS -0.43
    Price-to-Earnings (P/E) Ratio -5.26
    Price-to-Sales 46.70
    Price-to-Book 2.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.88
    Resistance 3 (R3) 2.93 2.76 2.78
    Resistance 2 (R2) 2.76 2.60 2.74 2.74
    Resistance 1 (R1) 2.51 2.51 2.43 2.47 2.71
    Pivot Point 2.35 2.35 2.31 2.33 2.35
    Support 1 (S1) 2.10 2.19 2.01 2.05 1.81
    Support 2 (S2) 1.93 2.09 1.91 1.78
    Support 3 (S3) 1.68 1.93 1.74
    Support 4 (S4) 1.64